NuCana plc
NCNANASDAQHealthcare● Active
$2.05
+$0.10(+5.13%)
Market Cap$12447764
P/E Ratio—
52W High$40
52W Low$1.33
NuCana plc (NCNA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NCNA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$1.25
Est. -$2.64 · +52.7%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS🔥 4-Quarter EPS Beat Streak
NCNA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$2.68 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$2.64 | -$1.25 | +52.7% | — | — | — |
| ▲ Q1 FY2026 | Mar 19, 2026 | -$2.69 | -$1.47 | +45.4% | — | — | — |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$2.69 | -$0.10 | +96.3% | — | — | — |
| ▲ Q3 FY2025 | Aug 20, 2025 | -$2.75 | -$0.16 | +94.2% | — | — | — |
| ▼ Q2 FY2025 | Jun 2, 2025 | -$2.58 | -$126.00 | -4778.1% | — | — | — |
| ▲ Q1 FY2025 | Mar 20, 2025 | -$486.00 | -$64.00 | +86.8% | — | — | — |
| ▼ Q4 FY2024 | Nov 25, 2024 | -$3.47 | -$456.00 | -13041.2% | — | — | — |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$2.68
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$1.25
EPS Est.
-$2.64
EPS Surpr.
+52.7%
Revenue
—
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
-$1.47
EPS Est.
-$2.69
EPS Surpr.
+45.4%
Revenue
—
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.10
EPS Est.
-$2.69
EPS Surpr.
+96.3%
Revenue
—
Q3 FY2025
Aug 20, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$2.75
EPS Surpr.
+94.2%
Revenue
—
Q2 FY2025
Jun 2, 2025Miss
EPS Actual
-$126.00
EPS Est.
-$2.58
EPS Surpr.
-4778.1%
Revenue
—
Q1 FY2025
Mar 20, 2025Beat
EPS Actual
-$64.00
EPS Est.
-$486.00
EPS Surpr.
+86.8%
Revenue
—
Q4 FY2024
Nov 25, 2024Miss
EPS Actual
-$456.00
EPS Est.
-$3.47
EPS Surpr.
-13041.2%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-25.02 | $-25.02 | $-25.02 | 1 |
| Q3 FY2027 | $-14.78 | $-14.78 | $-14.78 | 1 |
| Q2 FY2027 | $-8.28 | $-8.28 | $-8.28 | 1 |
| Q1 FY2027 | $-4.60 | $-4.60 | $-4.60 | 1 |
| Q4 FY2026 | $-2.04 | $-2.04 | $-2.04 | 1 |
| Q3 FY2026 | $-2.04 | $-2.04 | $-2.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +52.7% | $1.87 | $1.98 | +5.88% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +45.4% | $1.74 | $1.71 | -1.72% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +96.3% | $3.79 | $3.49 | -7.92% |
| ▲ Q3 FY2025 | Aug 20, 2025 | +94.2% | $3.56 | $3.11 | -12.64% |
| ▼ Q2 FY2025 | Jun 2, 2025 | -4778.1% | $7.06 | $7.60 | +7.65% |
| ▲ Q1 FY2025 | Mar 20, 2025 | +86.8% | $169.00 | $161.40 | -4.50% |
| ▼ Q4 FY2024 | Nov 25, 2024 | -13041.2% | $246.00 | $252.00 | +2.44% |
| ▼ Q3 FY2024 | Aug 15, 2024 | -6.8% | $626.00 | $658.00 | +5.11% |
Q2 FY2026+5.88%
Report Date
May 14, 2026
EPS Beat/Miss
+52.7%
Price Before
$1.87
Price After
$1.98
Q1 FY2026-1.72%
Report Date
Mar 19, 2026
EPS Beat/Miss
+45.4%
Price Before
$1.74
Price After
$1.71
Q4 FY2025-7.92%
Report Date
Nov 13, 2025
EPS Beat/Miss
+96.3%
Price Before
$3.79
Price After
$3.49
Q3 FY2025-12.64%
Report Date
Aug 20, 2025
EPS Beat/Miss
+94.2%
Price Before
$3.56
Price After
$3.11
Q2 FY2025+7.65%
Report Date
Jun 2, 2025
EPS Beat/Miss
-4778.1%
Price Before
$7.06
Price After
$7.60
Q1 FY2025-4.50%
Report Date
Mar 20, 2025
EPS Beat/Miss
+86.8%
Price Before
$169.00
Price After
$161.40
Q4 FY2024+2.44%
Report Date
Nov 25, 2024
EPS Beat/Miss
-13041.2%
Price Before
$246.00
Price After
$252.00
Q3 FY2024+5.11%
Report Date
Aug 15, 2024
EPS Beat/Miss
-6.8%
Price Before
$626.00
Price After
$658.00
Avg Beat Reaction-4.18%
Avg Miss Reaction+5.07%
Beat Rate5 / 8 quarters
Largest Move-12.64% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NCNA ends December
NuCana plc (NCNA) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-1.25 — beating the analyst consensus of $-2.64 by +52.7%. NCNA has beaten EPS estimates for 4 consecutive quarters. The next NCNA earnings date is expected around September 1, 2026.
Each quarter, investors track NCNA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NCNA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NCNA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NCNA earnings · 5 questionsNuCana plc's next earnings report is expected around September 1, 2026. NCNA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NCNA historically reports after market close (AMC).
NCNA earnings datewhen is NCNA earningsNCNA next earnings datewhen does NCNA report earningsNCNA earnings calendar
▸ Source: FMP · NuCana plc SEC filings · US GAAP · NuCana plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026